Immunologic Research

, Volume 13, Issue 2–3, pp 186–206 | Cite as

Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies

  • Mary H. Foster
  • Thomas Kieber-Emmons
  • Michael Ohliger
  • Michael P. Madaio


To determine the structure of three nuclear localizing lupus anti-DNA immunoglobulins (Igs) and to search for clues to mechanisms of cellular and/or nuclear access, their H- and L-chain variable region sequences were determined and subjected to three-dimensional modeling. Although the results indicate heterogeneity in their primary structures, the H chains are encoded by 3 members of the J558 VH gene family with a common tertiary conformation that is not shared by a J558-encoded nonnuclear localizing anti-DNA control Ig. Furthermore, at least two of the Igs share a conformational motif in the H-chain CDR3, and all three Igs contain multiple positively charged amino acids in their CDRs, resembling nuclear localization signals that direct protein nuclear import. Notably, each VH and VK gene is also found recurrently among previously described autoantibodies. Molecular analysis further indicates that both germline-encoded and significantly mutated V genes can generate nuclear localizing anti-DNA Ig.

Key Words

Anti-DNA Autoantibodies Nuclear localization Lupus V genes, variable-region genes Antibody modeling Tertiary conformation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andersen I, Anderson P, Elling P, Graudal H: Epidermal nuclear immunoglobulin deposits in some connective tissue diseases: Correlations with ENA antibodies. Ann Rheum Dis 1983;42:163–167.PubMedGoogle Scholar
  2. 2.
    Chen ZY, Dobson RL, Ainsworth SK, Silver RM, Maricq HR: Epidermal nuclear immunofluorescence: Serological correlations supporting an in vivo reaction. Br J Dermatol 1985;112:15–22.PubMedGoogle Scholar
  3. 3.
    Baart de la Faille-Kuyper EH: In vivo nuclear localization of immunoglobulins in clinically normal skin in systemic and procainamide induced lupus erythematosus. Neth J Med 1974;17:58.Google Scholar
  4. 4.
    Gilliam JN: The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZBxNZW/F1 hybrid mice. J Invest Dermatol 1975;65:154–161.PubMedGoogle Scholar
  5. 5.
    Izuno GT: Observations on the in vivo reaction of antinuclear antibodies with epidermal cells. Br J Dermatol 1978;98:391–398.PubMedGoogle Scholar
  6. 6.
    McCoy RC: Nuclear Localization of Immunoglobulins in renal biopsies of patients with lupus nephritis. Am J Pathol 1972;68:469–478.PubMedGoogle Scholar
  7. 7.
    Tan M, Kunkel HG: Immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum 1966;9:37–46.PubMedGoogle Scholar
  8. 8.
    Iwatsuki K, Tagami H, Imaizumi S, Ginoza M, Yamada M: The speckled epidermal nuclear immunofluorescence of mixed connective tissue disease seems to develop as an in vitro phenomenon. Br J Dermatol 1982;107:653–657.PubMedGoogle Scholar
  9. 9.
    Wells JV, Webb J, Van Deventer M, Fry B, Pollard KM, Raftos J, Monk W, Nelson DS: In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases. Clin Exp Immunol 1979;38:424–435.PubMedGoogle Scholar
  10. 10.
    Koelle MS, Kumar V, Beutner EH, Chorzelski TP: In-vivo epidermal nuclear reactions: A selective process. Br J Dermatol 1991;125:48–52.PubMedGoogle Scholar
  11. 11.
    Burrows NP, Bhogal BS, Russell Jones R, Black MM: Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence. J Cutan Pathol 1993;20:159–162.PubMedGoogle Scholar
  12. 12.
    Dingwall C, Laskey RA: Protein import into the cell nucleus. Annu Rev Cell Biol 1986;2:365–388.Google Scholar
  13. 13.
    Newmeyer DD, Forbes DJ: Nuclear import can be separated into distinct steps in vitro: Nuclear pore binding and translocation. Cell 1988;52:641–653.PubMedGoogle Scholar
  14. 14.
    Silver PA: How proteins enter the nucleus. Cell 1991;64:489–497.PubMedGoogle Scholar
  15. 15.
    Andres RY, Jeng I, Bradshaw RA: Nerve growth factor receptors: Identification of distinct classes in plasma membranes and nuclei of embryonic dorsal root neurons. Proc Natl Acad Sci USA 1977;74:2785–2789.PubMedGoogle Scholar
  16. 16.
    Giss BJ, Walker AM: Mammotroph autoregulation: intracellular fate of internalized prolactin. Mol Cell Endocrinol 1985;42:259–267.PubMedGoogle Scholar
  17. 17.
    Clevenger CV, Sillman AL, Prystowsky MB: Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes. Endocrinology 1990;127:3151–3159.PubMedGoogle Scholar
  18. 18.
    Clevenger CV, Russell DH, Appasamy PM, Prystowsky MB: Regulation of IL2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci USA 1990;87:6460–6464.PubMedGoogle Scholar
  19. 19.
    Grenfell S, Smithers N, Miller K, Solari R: Receptor-mediated endocytosis and nuclear transport of human interleukin 1a. Biochem J 1989;264:813–822.PubMedGoogle Scholar
  20. 20.
    Haigler H, Ash JF, Singer SJ, Cohen S: Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci USA 1978;75:3317–3321.PubMedGoogle Scholar
  21. 21.
    Massague J, Kelly B: Internalization of transforming growth factor-b and its receptor in BALB/c 3T3 fibroblasts. J Cell Physiol 1986;128:216–222.PubMedGoogle Scholar
  22. 22.
    Johnson LK, Vlodavsky I, Baxter JD, Gospodarowicz D: Nuclear accumulation of epidermal growth factor in cultured rat pituitary cells. Nature 1980;287:340–343.PubMedGoogle Scholar
  23. 23.
    Savion N, Vlodavsky I, Gospodarowicz D: Nuclear accumulation of epidermal growth factor in cultured bovine corneal endothelial and granulosa cells. J Biol Chem 1981;256:1149–1154.PubMedGoogle Scholar
  24. 24.
    Baldin V, Roman AM, Bosc-Bierne I, Amalric F, Bouche G: Translocation of bFGF to the nucleus is G1 phase specific in bovine aortic endothelial cells. EMBO J 1990;9:1511–1517.PubMedGoogle Scholar
  25. 25.
    Rakowicz-Szulczynska EM, Rodeck U, Herlyn M, Koprowski H: Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. Proc Natl Acad Sci USA 1986;83:3728–3732.PubMedGoogle Scholar
  26. 26.
    Rifkin DB, Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989;109:1–6.PubMedGoogle Scholar
  27. 27.
    Yankner BA, Shooter EM: Nerve growth factor in the nucleus: Interaction with receptors on the nuclear membrane. Proc Natl Acad Sci USA 1979;76:1269–1273.PubMedGoogle Scholar
  28. 28.
    Hendry IA, Stoeckel K, Thoenen H, Iversen LL: The retrograde axonal transport of nerve growth factor. Brain Res 1974;68:103–121.PubMedGoogle Scholar
  29. 29.
    Friesel R, Maciag T: Internalization and degradation of heparin binding growth factor-1 by endothelial cells. Biochem Biophys Res Commun 1988;151:957–964.PubMedGoogle Scholar
  30. 30.
    Imamura T, Engleka K, Zhan X, Tokita Y, Forough R, Roeser D, Jackson A, Maier JAM, Hla T, Maciag T: Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 1990;249:1567–1570.PubMedGoogle Scholar
  31. 31.
    Peralta Soler A, Thompson KA, Smith RM, Jarett L: Immunological demonstration of the accumulation of insulin, but not insulin receptors, in nuclei of insulin-treated cells. Proc Natl Acad Sci USA 1989;86:6640–6644.Google Scholar
  32. 32.
    Smith RM, Jarett L: Differences in adenosine triphosphate dependency of receptor-mediated endocytosis of alpha 2-macroglobulin and insulin correlate with separate routes of ligand-receptor complex internalization. Endocrinology 1990;126:1551–1560.PubMedGoogle Scholar
  33. 33.
    Stoeckel K, Guroff G, Schwab M, Thoenen H: The significance of retrograde axonal transport for the accumulation of systematically administered nerve growth factor (NGF) in the rat superior cervical ganglion. Brain Res 1976;109:271–284.PubMedGoogle Scholar
  34. 34.
    Morel G: Internalization and nuclear localization of peptide hormones. Biochem Pharmacol 1994; 47:63–76.PubMedGoogle Scholar
  35. 35.
    Alarcon-Segovia D, Rutz-Arguelles A, Fishbein E: Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 1978;271:67–69.PubMedGoogle Scholar
  36. 36.
    Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L: Antibody penetration into living cells. II. Antiribonucleo-protein IgG penetrates into T lymphocytes causing their deletion and the abrogation of suppressor function. J Immunol 1979;122:1855–1862.PubMedGoogle Scholar
  37. 37.
    Alarcon-Segovia D, Lorente L: Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T cells. Clin Exp Immunol 1983;52:365–371.PubMedGoogle Scholar
  38. 38.
    Okudaira K, Searles RP, Tanimoto K, Koriuchi KY, Williams RC Jr: T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus. J Clin Invest 1982;69:1026–1038.PubMedGoogle Scholar
  39. 39.
    Golan TD, Gharavi AE, Elkon KB: Penetration of autoantibodies into living epithelial cells. J Invest Dermatol 1993;100:316–322.PubMedGoogle Scholar
  40. 40.
    Okudaira K, Hisayoshi Y, Williams RC: Monoclonal anti-DNA antibody interacts with living mononuclear cells. Arthritis Rheum 1987; 30:669–678.PubMedGoogle Scholar
  41. 41.
    Vlahakos DV, Foster MH, Ucci AA, Barrett KJ, Datta SK, Madaio MP: Murine monoclonal anti-DNA antibodies penetrate cells bind to nuclei and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol 1992;2:1345–1354.PubMedGoogle Scholar
  42. 42.
    Yanase K, Smith RM, Cizman B, Foster MH, Peachey LD, Jarett L, Madaio MP: A subgroup of murine monoclonal anti-deoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time- and temperature-dependent manner. Lab Invest 1994;71:52–60.PubMedGoogle Scholar
  43. 43.
    Foster MH, MacDonald M, Barrett KJ, Madaio MP: VH gene analysis of spontaneously activated B cells in adult MRL-lpr/lpr mice. The J558 bias is not limited to classic lupus autoantibodies. J Immunol 1991; 147:1504–1511.PubMedGoogle Scholar
  44. 44.
    Trepicchio W Jr, Maruya A, Barrett KJ: The heavy chain genes of a lupus anti-DNA autoantibody are encoded in the germ line of a nonautoimmune strain of mouse and conserved in strains of mice polymorphic for this gene locus. J Immunol 1987;139:3139–3145.PubMedGoogle Scholar
  45. 45.
    Foster MH, Madaio MP, Barrett KJ: Variable region sequence analysis of anti-DNA antibodies: Evidence for a family of closely related germline VH genes encoding lupus autoantibodies. DNA Cell Biol 1992;11:175–182.PubMedCrossRefGoogle Scholar
  46. 46.
    Foster MH, Sabbaga J, Line SRP, Thompson KS, Barrett KJ, Madaio MP: Molecular analysis of nephrotropic anti-laminin antibodies from an MRL/lpr autoimmune mouse. J Immunol 1993;151:814–824.PubMedGoogle Scholar
  47. 47.
    Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989.Google Scholar
  48. 48.
    Brutlag DL, Dautricourt J, Maulik S, Relph J: Improved sensitivity of biological sequence database searches. Comput Appl Biol Sci 1990;6:237–245.PubMedGoogle Scholar
  49. 49.
    Tramontano A, Lesk AM: Common features of the conformation of antigen-binding loops in immunoglobulins and application to modeling loop conformations. Proteins 1992; 13:231–245.PubMedGoogle Scholar
  50. 50.
    Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G: Structural repertoire of the human VH segments. J Mol Biol 1992;227:799–817.PubMedGoogle Scholar
  51. 51.
    Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR: Conformations of immunoglobulin hypervariable regions. Nature 1989;342:877–883.PubMedGoogle Scholar
  52. 52.
    Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M: The protein databank: A computer-based archival file for macromolecular structure. J Mol Biol 1977;112:535–542.PubMedGoogle Scholar
  53. 53.
    Blundell TL, Sibanda BL, Sternberg MJ, Thornton JM: Knowledge-based prediction of protein structures and the design of novel molecules. Nature 1987;326:347–352.PubMedGoogle Scholar
  54. 54.
    Bruccoleri RE, Haber E, Novotny J: Structure of antibody hypervariable loops reproduced by a conformational search algorithm (published erratum appears in Nature 1988; 336:266. Nature 1988;335:564–568.PubMedGoogle Scholar
  55. 55.
    Mas MT, Smith KC, Yarmush DL, Aisaka K, Fine RM: Modeling the anti-CEA antibody combining site by homology and conformational search. Proteins 1992;14:483–498.PubMedGoogle Scholar
  56. 56.
    Martin A, Cheetham J, Rees A: Modeling antibody hypervariable loops: A combined algorithm. Proc Natl Acad Sci USA 1989;86:9268–9272.PubMedGoogle Scholar
  57. 57.
    Fine RM, Wang H, Shenkin PS, Yarmush DL, Levinthal C: Predicting antibody hypervariable loop conformations. II. Minimization and molecular dynamics studies of MCPC603 from many randomly generated loop conformations. Proteins 1986;1:342–362.PubMedGoogle Scholar
  58. 58.
    Shenkin PS, Yarmush DL, Fine RM, Wang HJ, Levinthal C: Predicting antibody hypervariable loop conformation. I. Ensembles of random conformations for ringlike structures. Biopolymers 1987;26:2053–2085.PubMedGoogle Scholar
  59. 59.
    Karp SL, Kieber-Emmons T, Sun MJ, Wolf G, Neilson EG: The molecular structure of cross-reacting idiotype on autoantibodies recognizing parenchymal self. J Immunol 1993;150:867–879.PubMedGoogle Scholar
  60. 60.
    Tomiyama Y, Brojer E, Ruggeri ZM, Shattil SJ, Smiltneck J, Gorski J, Kumar A, Kieber-Emmons T, Kunicki TJ: A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3. J Biol Chem 1992;267:18085–18092.PubMedGoogle Scholar
  61. 61.
    Jones TA, Thirup S: Using known substructures in protein model building and crystallography. EMBO J 1986;5:819–822.PubMedGoogle Scholar
  62. 62.
    Seeman NC, Rosenberg JM, Rich A: Sequence-specific recognition of double helical nucleic acids by proteins. Proc Natl Acad Sci USA 1976: 73:804.PubMedGoogle Scholar
  63. 63.
    Shlomchik M, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A, Weigert M: Anti-DNA autoantibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171:265–292.PubMedGoogle Scholar
  64. 64.
    Marion T, Bothwell A, Briles D, CA Janeway J: IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection. J Immunol 1989; 142:4269.PubMedGoogle Scholar
  65. 65.
    Marion TN, Tillman DM, Jou NT: Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse. J Immunol 1990;145:2322–2332.PubMedGoogle Scholar
  66. 66.
    Tillman D, Jou N-T, Hill R, Marion T: Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J Exp Med 1992; 176:761–779.PubMedGoogle Scholar
  67. 67.
    Kofler R, Strohal R, Balderas RS, Johnson ME, Noonan DJ, Duchosal MA, Dixon FJ, Theofilopoulos AN: Immunoglobulin κ light chain variable region gene complex organization and immunoglobulin genes encoding anti-DNA autoantibodies in lupus mice. J Clin Invest 1988;82:852–860.PubMedGoogle Scholar
  68. 68.
    Eilat D, Webster DW, Rees AR: V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice. J Immunol 1988;141:1745–1753.PubMedGoogle Scholar
  69. 69.
    Radic MZ, Mascelli MA, Erikson J, Shan H, Shlomchik M, Weigert M: Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harb Symp Quant Biol 1989; 54:933–945.PubMedGoogle Scholar
  70. 70.
    Smith RG, Voss JEW: Variable region primary structures of monoclonal anti-DNA autoantibodies from NZB/NZW F1 mice. Mol Immunol 1990;27:463–470.PubMedGoogle Scholar
  71. 71.
    O'Keefe T, Bandyopadhyay S, Datta S, Imanishi-Kari T: V region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies. J Immunol 1990;144:4275–4283.PubMedGoogle Scholar
  72. 72.
    Behar SM, Lustgarten DL, Corbet S, Scharff MD: Characterization of somatically mutated S107 VH11-encoded anti-DNA autoantibodies derived from autoimmune (NZB x NZW)F1 mice. J Exp Med 1990; 173:731.Google Scholar
  73. 73.
    Eilat D, Fischel R: Recurrent utilization of genetic elements in V regions of antinucleic acid antibodies from autoimmune mice. J Immunol 1991;147:361–368.PubMedGoogle Scholar
  74. 74.
    Dersimonian H, McAdam KPWJ, Mackworth-Young C, Stollar BD: The recurrent expression of variable region segments in human IgM anti-DNA autoantibodies. J Immunol 1989;142:4027.PubMedGoogle Scholar
  75. 75.
    Cairns E, Kwong PC, Misener V, Ip P, Bell DA, Siminovitch KA: Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. Implications for the molecular basis of autoimmune responses. J Immunol 1989;143:685–691.PubMedGoogle Scholar
  76. 76.
    Thompson WS, Gross RH: Antibodies introduced into living cells with liposomes localize specifically and inhibit specific intracellular processes. Gene Anal Tech 1988;5:73–79.PubMedGoogle Scholar
  77. 77.
    Einck L, Bustin M: Functional histone antibody fragments traverse the nuclear envelope. J Cell Biol 1984;98:205–213.PubMedGoogle Scholar
  78. 78.
    Biocca S, Neuberger MS, Cuttaneo A: Expression and targeting of intracellular antibodies in mammalian cells. EMBO J 1990;9:101–108.PubMedGoogle Scholar
  79. 79.
    Madsen P, Nielsen S, Celis JE: Monoclonal antibody specific for human nuclear proteins IEF 8Z30 and 8Z31 accumulates in the nucleus a few hours after cytoplasmic microinjection of cells expressing these proteins. J Cell Biol 1986;103:2083–2089.PubMedGoogle Scholar
  80. 80.
    Valle G, Jones EA, Colman A: Antiovalbumin monoclonal antibodies interact with their antigen in internal membranes ofXenopus oocytes. Nature 1982;300:71–74.PubMedGoogle Scholar
  81. 81.
    Goldfarb DS, Gariepy J, Schoolnik G, Kornberg RD: Synthetic peptides as nuclear localization signals. Nature 1986;322:641–644.PubMedGoogle Scholar
  82. 82.
    Lanford RE, Kanda P, Kennedy RC: Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell 1986;46:575–582.PubMedGoogle Scholar
  83. 83.
    Yoneda Y, Semba T, Kaneda Y, Noble RL, Matsuoka Y, Kurihara T, Okada Y, Imamoto N: A long synthetic peptide containing a nuclear localization signal and its flanking sequences of SV40 T-antigen directs the transport of IgM into the nucleus efficiently. Exp Cell Res 1992;201:313–320.PubMedGoogle Scholar
  84. 84.
    Wolff B, Park MK, Klima E, Hanover JA: Antibodies against the SV40 large T antigen nuclear localization sequence. Arch Biochem Biophys 1991;288:131–140.PubMedGoogle Scholar
  85. 85.
    Boulikas T: Nuclear localization signals (NLS). Crit Rev Eukaryot Gene Expr 1993;3:193–227.PubMedGoogle Scholar
  86. 86.
    Yanase K, Smith RM, Jarett L, Foster MH, Madaio MP: Identification of a cell surface receptor that mediates cellular entry of a nuclear localizing lupus autoantibody (abstract). J Am Soc Nephrol 1994;5:774.Google Scholar
  87. 87.
    Jacob L, Lety MA, Louvard D, Bach JF: Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest 1985;75:315–317.PubMedGoogle Scholar
  88. 88.
    Jacob L, Lety M, Monteiro R, Jacob F, Bach J, Louvard D: Altered cell-surface protein(s), crossreactive with DNA, on spleen cells of autoimmune lupus mice. Proc Natl Acad Sci USA 1987;84:1361–1363.PubMedGoogle Scholar
  89. 89.
    Frampton G, Hobby P, Morgan A, Staines NA, Cameron JS: A role for DNA in anti-DNA antibodies binding to endothelial cells. J Autoimmun 1991;4:463–478.PubMedGoogle Scholar
  90. 90.
    Bachmann M, Chang S, Bernd A, Mayet W, Meyer zum Büschenfelde KH, Muller WE: Translocation of the nuclear autoantigen La to cell surface: Assembly and disassembly with the extracellular matrix. Autoimmunity 1991;9:99–107.PubMedCrossRefGoogle Scholar
  91. 91.
    Liu AY, Robinson RR, Murray EDJ, Ledbetter JA, Hellstroem I, Hellstroem KE: Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity. J Immunol 1987;139:3521–3526.PubMedGoogle Scholar
  92. 92.
    Zenke G, Zeder G, Strittmatter U, Anderson E, Kocher HP, Quesniaux VFJ, Schreier MH, Van Regenmortel MHV: Anti-cyclosporine monoclonal antibodies and their anti-idiotypic counterpart: Structure and biological activity. Mol Immunol 1992;29:343–351.PubMedGoogle Scholar
  93. 93.
    Mo JA, Bona CA, Holmdahl R: Variable region gene selection of immunoglobulin C expressing B cells with specificity for a defined epitope on type II collagen. Eur J Immunol 1993;23:2503–2510.PubMedGoogle Scholar
  94. 94.
    Winter E, Radbruch A, Krawinkel U: Members of novel VH gene families are found in VDJ regions of polyclonally activated B-lymphocytes. EMBO J 1985;4:2861–2867.PubMedGoogle Scholar
  95. 95.
    Tarlinton D, Foerster I, Rajewsky K: An explanation for the defect in secretion of IgM Mott cells and their predominant occurrence in the Ly-1 B cell compartment. Eur J Immunol 1992;22:531–539.PubMedGoogle Scholar
  96. 96.
    Novick KE, Fasy TM, Losman MJ, Monestier M: Polyreactive IgM antibodies generated from autoimmune mice and selected for histone-binding activity. Int Immunol 1992;4:1103–1111.PubMedGoogle Scholar
  97. 97.
    Lehuen A, Bartels JH, Kearney JF: Characterization, specificity and IgV gene usage of anti-lymphocyte monoclonal antibodies from perinatal mice. Int Immunol 1992;4:1073–1084.PubMedGoogle Scholar
  98. 98.
    Cottet M-H, Bordenave G: Epitope complementarity and idiotypic interactions: A study of idiotypic-like interactions between anticytidine and anti-guanosine A/J mouse monoclonal antibodies. Mol Immunol 1994;31:65–74.PubMedGoogle Scholar
  99. 99.
    Darsley MJ, Rees AR: Nucleotide sequences of five anti-lysozyme monoclonal antibodies. EMBO J 1985;4:393–398.PubMedGoogle Scholar
  100. 100.
    De Waele P, Feys V, Van de Voorde A, Molemans F, Fiers W: Expression in non-lymphoid cells of mouse recombinant immunoglobulin directed against the tumour marker human placental alkaline phosphatase. Eur J Biochem 1988;176:287–298.PubMedGoogle Scholar
  101. 101.
    Rathbun GA, Otani F, Milner EC, Capra JD, Tucker PW: Molecular characterization of the A/J J558 family of heavy chain variable region gene segments. J Mol Biol 1988;202:383–395.PubMedGoogle Scholar
  102. 102.
    Takeda Y, Wise KS, Hoffman RW: Nucleotide sequences of immunoglobulin heavy and light chain V-regions from a monoclonal autoantibody specific for a unique set of small nuclear ribonucleoprotein complexes. Nucleic Acids Res 1992;20:4099.PubMedGoogle Scholar
  103. 103.
    Losman M, Fasy TM, Novick KE, Monestier M: Relationships among antinuclear autoantibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. Int Immunol 1993;5:513–523.PubMedGoogle Scholar
  104. 104.
    Monestier M, Fasy TM, Losman MJ, Novick KE, Muller S: Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice. Mol Immunol 1993;30:1069–1075.PubMedGoogle Scholar
  105. 105.
    Calcutt MJ, Kremer MT, Giblin MF, Quinn TP, Deutscher SL: Isolation and characterization of nucleic acid-binding antibody fragments from autoimmune mice-derived bacteriophage display libraries. Gene 1993;137:77–83.PubMedGoogle Scholar
  106. 106.
    Kanzy EJ, Kurrle R: Construction, expression and characterization of humanized antibodies directed against the human alpha/beta T cell receptor. J Immunol 1992;147:4366–4373.Google Scholar
  107. 107.
    Shlomchik M, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert M: The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805–811.PubMedGoogle Scholar
  108. 108.
    Takahashi S, Itoh J, Nose M, Ono M, Yamamoto T, Kyogoku M: Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse. Mol Immunol 1993;30:177–182.PubMedGoogle Scholar
  109. 109.
    Koizumi T, Puccetti A, Migliorini P, Barrett KJ, Schwartz RS: Molecular heterogeneity of auto-anti-idiotypic antibodies in MRL-lpr/lpr mice. Eur J Immunol 1991;21:2185–2193.PubMedGoogle Scholar
  110. 110.
    Mocikat R, Kuetemeier G, Hoffmann-Fezer G, Thierfelder S: A mouse model for the preclinical evaluation of immunosuppressive effector functions of human isotypes. The human IgG1 isotype is superior to IgG3. Transplantation 1994;57:405–411.PubMedGoogle Scholar
  111. 111.
    Mueller B, Reth M: Ordered activation of the Ig(lambda) locus in Abelson B cell lines. J Exp Med 1988;168:2131–2137.Google Scholar
  112. 112.
    Ewolonu UK, Nell LJ, Thomas JW: V-H and V-L gene usage by murine IgG antibodies that bind autologous insulin. J Immunol 1990;144:3091–3098.Google Scholar
  113. 113.
    Buckel P, Huebner-Parajsz C, Mattes R, Lenz H, Haug H, Beaucamp K: Cloning and nucleotide sequence of heavy- and light-chain cDNAs from a creatine-kinase-specific monoclonal antibody. Gene 1987;51:13–19.PubMedGoogle Scholar
  114. 114.
    Gilkeson GS, Bloom DD, Pisetsky DS, Clarke SH: Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. J Immunol 1993;151:1353–1364.PubMedGoogle Scholar
  115. 115.
    Bloom DD, Davignon J-L, Retter MW, Shlomchik MJ, Pisetzky DS, Cohen PL, Eisenberg RA, Clarke SH: V region gene analysis of antism hybridomas from MRL/mplpr/lpr mice. J Immunol 1993;150:1591–1610.PubMedGoogle Scholar
  116. 116.
    Bespalov IA, Shiyanov PA, Lukashevich LV, Lunev VE, Tribush SS, Gaponova GI, Deyev SM: Production of a single-chain antibody against human ferritin inEscherichia coli. Mol Biol (Mosk) 1993; 27:451–460.Google Scholar
  117. 117.
    Caulfield MJ, Stanko D: A pathogenic monoclonal antibody, G8, is characteristic of antierythrocyte autoantibodies from Coombs'-positive NZB mice. J Immunol 1992; 148:2068–2073.PubMedGoogle Scholar
  118. 118.
    Nishioka Y, Leder P: Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes. J Biol Chem 1980;255:3691–3694.PubMedGoogle Scholar
  119. 119.
    Vandevyver C, Steukers M, Lambrechts J, Heyligen H, Raus J: Development and functional characterization of a murine/human chimeric antibody with specificity for the human interleukin-2 receptor. Mol Immunol 1993;30:865–876.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1994

Authors and Affiliations

  • Mary H. Foster
    • 1
  • Thomas Kieber-Emmons
    • 2
  • Michael Ohliger
    • 1
  • Michael P. Madaio
    • 1
  1. 1.Penn Center for Molecular Studies of Kidney Diseases Renal-Electrolyte and Hypertension Division, Department of MedicineUniversity of PennsylvaniaPhiladelphia(USA)
  2. 2.Wistar Institute of Biology and AnatomyPhiladelphiaUSA

Personalised recommendations